The effect of moxifloxacin and gatifloxacin on long-term visual outcomes following photorefractive keratectomy

Jenna M. Burka, Kraig S. Bower, R. Cameron VanRoekel, Richard Stutzman, Chrystyna P. Kuzmowych

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

PURPOSE: To compare the effect of gatifloxacin and moxifloxacin on visual outcomes after photorefractive keratectomy (PRK). METHODS: Thirty-five PRK patients were treated postoperatively with gatifloxacin (Zymar) in one eye and moxifloxacin (Vigamox) in the fellow eye. Postoperative regimens were otherwise identical. In a previous study (initial phase), we evaluated epithelial healing. In this study (second phase), we compared uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest spherical equivalent (MSE), and corneal haze at 6 months postoperatively for 32 patients using the Wilcoxon signed ranks test. RESULTS: No statistically significant difference was noted between eyes treated with Zymar and Vigamox in terms of UCVA, BSCVA, MSE, or corneal haze at 6 months postoperatively. Two (6%) Vigamox-treated eyes versus 0 (0%) Zymar-treated eyes lost one line of BSCVA from preoperative examination. Median UCVA and MSE were equivalent for both groups. CONCLUSIONS: At 6 months after PRK, there was no significant difference in visual outcomes with either antibiotic.

Original languageEnglish (US)
Pages (from-to)414-417
Number of pages4
JournalJournal of Refractive Surgery
Volume23
Issue number4
StatePublished - Apr 1 2007
Externally publishedYes

Fingerprint

Photorefractive Keratectomy
Visual Acuity
Nonparametric Statistics
moxifloxacin
gatifloxacin
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Ophthalmology

Cite this

The effect of moxifloxacin and gatifloxacin on long-term visual outcomes following photorefractive keratectomy. / Burka, Jenna M.; Bower, Kraig S.; VanRoekel, R. Cameron; Stutzman, Richard; Kuzmowych, Chrystyna P.

In: Journal of Refractive Surgery, Vol. 23, No. 4, 01.04.2007, p. 414-417.

Research output: Contribution to journalArticle

Burka, Jenna M. ; Bower, Kraig S. ; VanRoekel, R. Cameron ; Stutzman, Richard ; Kuzmowych, Chrystyna P. / The effect of moxifloxacin and gatifloxacin on long-term visual outcomes following photorefractive keratectomy. In: Journal of Refractive Surgery. 2007 ; Vol. 23, No. 4. pp. 414-417.
@article{36ea733782ab46cfae5bf7e385cbf111,
title = "The effect of moxifloxacin and gatifloxacin on long-term visual outcomes following photorefractive keratectomy",
abstract = "PURPOSE: To compare the effect of gatifloxacin and moxifloxacin on visual outcomes after photorefractive keratectomy (PRK). METHODS: Thirty-five PRK patients were treated postoperatively with gatifloxacin (Zymar) in one eye and moxifloxacin (Vigamox) in the fellow eye. Postoperative regimens were otherwise identical. In a previous study (initial phase), we evaluated epithelial healing. In this study (second phase), we compared uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest spherical equivalent (MSE), and corneal haze at 6 months postoperatively for 32 patients using the Wilcoxon signed ranks test. RESULTS: No statistically significant difference was noted between eyes treated with Zymar and Vigamox in terms of UCVA, BSCVA, MSE, or corneal haze at 6 months postoperatively. Two (6{\%}) Vigamox-treated eyes versus 0 (0{\%}) Zymar-treated eyes lost one line of BSCVA from preoperative examination. Median UCVA and MSE were equivalent for both groups. CONCLUSIONS: At 6 months after PRK, there was no significant difference in visual outcomes with either antibiotic.",
author = "Burka, {Jenna M.} and Bower, {Kraig S.} and VanRoekel, {R. Cameron} and Richard Stutzman and Kuzmowych, {Chrystyna P.}",
year = "2007",
month = "4",
day = "1",
language = "English (US)",
volume = "23",
pages = "414--417",
journal = "Journal of Refractive Surgery",
issn = "0883-0444",
publisher = "Slack Incorporated",
number = "4",

}

TY - JOUR

T1 - The effect of moxifloxacin and gatifloxacin on long-term visual outcomes following photorefractive keratectomy

AU - Burka, Jenna M.

AU - Bower, Kraig S.

AU - VanRoekel, R. Cameron

AU - Stutzman, Richard

AU - Kuzmowych, Chrystyna P.

PY - 2007/4/1

Y1 - 2007/4/1

N2 - PURPOSE: To compare the effect of gatifloxacin and moxifloxacin on visual outcomes after photorefractive keratectomy (PRK). METHODS: Thirty-five PRK patients were treated postoperatively with gatifloxacin (Zymar) in one eye and moxifloxacin (Vigamox) in the fellow eye. Postoperative regimens were otherwise identical. In a previous study (initial phase), we evaluated epithelial healing. In this study (second phase), we compared uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest spherical equivalent (MSE), and corneal haze at 6 months postoperatively for 32 patients using the Wilcoxon signed ranks test. RESULTS: No statistically significant difference was noted between eyes treated with Zymar and Vigamox in terms of UCVA, BSCVA, MSE, or corneal haze at 6 months postoperatively. Two (6%) Vigamox-treated eyes versus 0 (0%) Zymar-treated eyes lost one line of BSCVA from preoperative examination. Median UCVA and MSE were equivalent for both groups. CONCLUSIONS: At 6 months after PRK, there was no significant difference in visual outcomes with either antibiotic.

AB - PURPOSE: To compare the effect of gatifloxacin and moxifloxacin on visual outcomes after photorefractive keratectomy (PRK). METHODS: Thirty-five PRK patients were treated postoperatively with gatifloxacin (Zymar) in one eye and moxifloxacin (Vigamox) in the fellow eye. Postoperative regimens were otherwise identical. In a previous study (initial phase), we evaluated epithelial healing. In this study (second phase), we compared uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest spherical equivalent (MSE), and corneal haze at 6 months postoperatively for 32 patients using the Wilcoxon signed ranks test. RESULTS: No statistically significant difference was noted between eyes treated with Zymar and Vigamox in terms of UCVA, BSCVA, MSE, or corneal haze at 6 months postoperatively. Two (6%) Vigamox-treated eyes versus 0 (0%) Zymar-treated eyes lost one line of BSCVA from preoperative examination. Median UCVA and MSE were equivalent for both groups. CONCLUSIONS: At 6 months after PRK, there was no significant difference in visual outcomes with either antibiotic.

UR - http://www.scopus.com/inward/record.url?scp=34247189698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247189698&partnerID=8YFLogxK

M3 - Article

C2 - 17455838

AN - SCOPUS:34247189698

VL - 23

SP - 414

EP - 417

JO - Journal of Refractive Surgery

JF - Journal of Refractive Surgery

SN - 0883-0444

IS - 4

ER -